Determination of Caffeine Content in Ethanolic Extract of Robusta Coffee Beans (Coffea canephora) Using UV-Vis Spectrophotometry
DOI:
https://doi.org/10.33759/jrki.v8i2.936Keywords:
caffeine; Coffea canephora; coffee bean extract; UV-Vis spectrophotometryAbstract
Caffeine is one of the main bioactive compounds in robusta coffee beans (Coffea canephora) that has potential applications in pharmaceutical and cosmetic formulations, particularly for hair growth stimulation. This study aimed to determine the caffeine content in ethanolic extract of robusta coffee beans using UV-Visible spectrophotometry. The research was conducted using an experimental laboratory design. Robusta coffee bean extract was obtained by maceration using ethanol as the solvent. Qualitative identification of caffeine was followed by quantitative analysis using UV-Vis spectrophotometry at a maximum wavelength of 273 nm. A calibration curve was constructed using standard caffeine solutions, and the caffeine content of the extract was calculated based on the linear regression equation. The results showed that the calibration curve exhibited good linearity within the tested concentration range. Quantitative analysis revealed that the caffeine content of the ethanolic extract of robusta coffee beans was 221.58 mg/g extract, which is consistent with previously reported caffeine levels in Coffea canephora. These findings confirm that robusta coffee beans are a significant natural source of caffeine and support their potential utilization as raw material for pharmaceutical and cosmetic products. This study provides quantitative data that may serve as a scientific basis for further formulation development and quality control of caffeine-containing herbal products.
Downloads
References
Sutrisno S, et al. Comparative caffeine content of arabica and robusta coffee. Indones J Chem. 2023;23(2):456-463.
Evans WC. Trease and Evans’ Pharmacognosy. 16th ed. Elsevier; 2009.
Draelos ZD. Cosmetic Dermatology: Products and Procedures. 2nd ed. Wiley-Blackwell; 2016.
Yeager SE, et al. Chemical composition and bioactivity of Coffea canephora beans. J Food Compos Anal. 2023;115:104921. doi:10.1016/j.jfca.2022.104921
Fischer TW, et al. Caffeine and its pharmacological effects on hair follicles. Int J Dermatol. 2007;46(1):27-35.
Fischer TW, et al. Caffeine prolongs anagen phase of hair follicles. Br J Dermatol. 2014;171(3):563-572.
Völker S, et al. Topical caffeine and androgenetic alopecia. Skin Pharmacol Physiol. 2020;33(3):147-154.
Joaquin L, et al. Quantitative analysis of caffeine in coffee species. Anal Chem Res. 2023;38:100544.
Purnamasari V, et al. Hair growth stimulation of robusta coffee bean extract. J Ilm Farm. 2023;19(2):85-92.
Hidayah N, et al. Emulgel as a novel topical drug delivery system. Asian J Pharm. 2020;14(1):1-9.
Khan BA, et al. Emulgel: A promising topical drug delivery system. Drug Dev Ind Pharm. 2022;48(3):321-330.
Mustapha O, Salako BL. Advances in topical drug delivery systems. Pharmaceutics. 2021;13(4):567.
Apriani R, et al. Effect of carbopol concentration on emulgel characteristics. Indones J Pharm Sci. 2023;21(1):45-53.
Sabalingam M, Siriwardhene M. Recent developments in emulgel formulations. J Drug Deliv Sci Technol. 2022;68:103062.
Surella S, Godavari A. Herbal emulgel formulations for hair care. J Cosmet Sci. 2023;74(2):95-104.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Riset Kefarmasian Indonesia

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles published in The Jurnal Riset Kefarmasian Indonesia (JRKI) are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).
This license permits users to copy, redistribute, share, translate, adapt, and build upon the published material for non-commercial purposes, provided that appropriate credit is given to the original author(s) and the journal, a link to the license is provided, and any changes made are clearly indicated.
If users remix, transform, or build upon the material, they must distribute their contributions under the same license or a license permitted by the applicable ShareAlike terms.
The material may not be used for commercial purposes under this license without additional permission from the relevant copyright holder.
Authors retain copyright of their published works and grant The Jurnal Riset Kefarmasian Indonesia the right of first publication.
Full license terms are available at: https://creativecommons.org/licenses/by-nc-sa/4.0/





